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inv encodes invasin, which is the primary invasion factor of Yersinia enterocolitica. inv expression in vitro is
regulated in response to temperature, pH, and growth phase. In vitro, inv is maximally expressed at 26°C and
repressed at 37°C at neutral pH but, when the pH of the media is adjusted to 5.5, levels of inv expression at
37°C are comparable to those at 26°C. A previous genetic screen for regulators of inv identified RovA, which
was found to be required for activation of inv in vitro under all conditions tested as well as in vivo. Here we
describe a screen that has identified a negative regulator of inv expression, ymoA. The ymoBA locus was
identified by transposon mutagenesis as a repressor of inv expression in vitro at 37°C at neutral pH. This
mutant shows increased inv expression at 37°C. The mutant can be fully complemented for inv expression by
a plasmid expressing ymoA. These results indicate that YmoA plays a role in the negative regulation of inv.
Yersinia enterocolitica is a gram-negative human pathogen
capable of colonizing the gastrointestinal tract. Once the or-
ganism establishes itself within a host, it is able to cause a
variety of syndromes including enterocolitis, mesenteric
lymphadenitis, and terminal ileitis. Y. enterocolitica is normally
acquired through ingestion of contaminated food or water,
with swine serving as a major reservoir for strains pathogenic
to humans (5).
Colonization of the intestinal epithelium first requires that the
organism be able to survive the gastric barrier of the stomach.
Once in the small intestine, the organism is able to adhere to
specialized cells in the small intestine called M cells (14, 16). Y.
enterocolitica is able to transverse these cells, ending up in the
underlying lymphoid tissue (Peyer’s patches), where it is able to
replicate and spread to the mesenteric lymph nodes (7, 38).
Y. enterocolitica contains a variety of adherence and invasion
factors to aid the bacterium in establishing an infection. The
major adhesion and invasion molecules identified in Y. entero-
colitica are invasin, which is the primary invasion factor (38)
and which initiates cell penetration by binding to a subset of
1-integrins (19) found on the surface of M cells (8), YadA,
which is believed to be involved in adherence to intestinal
brush border membranes as well as mucus (24, 35, 39), and Ail,
which is involved in adherence and invasion as well as the
promotion of serum resistance (4, 27, 28, 40, 45).
Invasin is an outer membrane protein found in Y. enteroco-
litica and Yersinia pseudotuberculosis (18, 19, 28, 37). When
expressed in Escherichia coli, invasin is sufficient to promote
invasion of tissue culture cells (18, 28). inv mutants do not
colonize host tissues as well as wild-type bacteria at early time
points. However, inv mutants eventually colonize to wild-type
levels, presumably due to YadA and possibly Ail (38, 39). inv
is maximally expressed in late exponential to early stationary
phase in vitro and is regulated in response to changes in growth
conditions. When cultures are grown at 26°C at neutral pH, inv
expression is activated. In contrast, cultures grown at 37°C at
neutral pH repress inv expression. However, when the pH of
the media is adjusted to 5.5, levels of inv expression at 37°C are
comparable to those observed at 26°C (36).
A previous genetic screen for regulators of Y. enterocolitica
inv identified RovA (41), which was found to be required for
activation of inv in vitro under all conditions tested. Subse-
quently, a homologue of RovA was identified as the regulator
of inv in Y. pseudotuberculosis (44). Comparing inv expression
in wild-type Y. enterocolitica to inv expression in a rovA mutant
showed robust expression of inv in the wild type and little to no
expression in the rovA mutant. Additionally, Western blot
analysis of invasin in Peyer’s patches from mice 2 days postin-
fection demonstrated that RovA is also required for in vivo
expression of inv (41). However, preliminary analysis of the inv
promoter suggested there may also be a negative regulator of
inv. In this study we describe a screen that has identified YmoA
as a negative regulator of inv expression.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plasmids
used in this study are listed in Table 1. The “v” designation refers to strains
harboring the virulence plasmid; “c” refers to strains which have been cured of
the virulence plasmid. Bacterial cultures were grown in Luria-Bertani (LB) broth
at 26 or 37°C. When appropriate, antibiotics were used at the following concen-
trations: ampicillin, 100 g ml1; chloramphenicol, 25 (for growth of E. coli) and
12.5 g ml1 (for growth of Y. enterocolitica); kanamycin, 50 g ml1; nalidixic
acid, 20 g ml1; spectinomycin, 50 g ml1; streptomycin, 50 g ml1.
Strain and plasmid construction. To construct the inv-gfp transcriptional fu-
sions, gfp was amplified from pKENmut2 (9) with primer GFP#1, which has a
SacII linker (5-TCC CCG CGG GGA AAG AAG GAG ATA TAC ATA TGA
GT-3), and primer GFP#2, which has a SacI linker (5-CGA GCT CGT ATT
TGT ATA GTT CAT CCA TGC C-3). The amplified fragment contained a
ribosome binding site and the coding region of the gfp gene. The PCR product
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was initially subcloned into the TA cloning vector pCR2.1 (Invitrogen) to gen-
erate pBY1. Subsequently, the SacII/SacI gfp fragment was subcloned into the
SacII/SacI sites of pWKS30:StrSpec (46) to generate pBY8. To generate the
inv-gfp transcriptional fusion, the full-length inv promoter region 415 to 170
(36) was subcloned from pREV2 via the 5 BamHI site and the 3 NotI site into
pBY8 to generate pBY10. Primer inv#3 (5-GCA TTT CAT TTG TCA TTG
C-3) and primer inv#1 (5-CCG ATC GAT AAT ATT AGC C-3) were used to
amplify the 215-bp (69 to 170) inv promoter fragment, which was cloned into
pCR2.1 to generate pBY11. The 215-bp fragment was then subcloned into pBY8
via 5 BamHI and 3 NotI sites within the polylinker of pCR2.1, generating
pBY12. Plasmids were confirmed by sequencing.
To complement the mutation in YVM567c, plasmids pKN43 and pELL21
were constructed. To generate pKN43, ymoB was amplified from JB580v with
primer ybaJ-5.2, which contains an EcoRI linker (5-GGA ATT CCG GTG AGC
GGA GAA ATG ATT TAT ATT AAT A-3), and primer ybaJ-3.2, which
contains an EcoRI linker (5-GGA ATT CCT CAA TAT AAA AAT AAT ATA
GGG AAA CTA TCC-3). The resulting product was cloned into the EcoRI site
of pWKS30:StrSpec. pELL21 was constructed by digesting pELL13 with EcoRI/
XbaI; the resulting fragment contained a deletion of ymoB, leaving ymoA under
the control of its native promoter. The fragment was subcloned into the EcoRI/
XbaI sites of pWKS30:StrSpec. Plasmids were confirmed by sequencing.
lacZ transcriptional fusions were generated by cloning PCR fragments into
pKN8 (3) and mating recipient (Y. enterocolitica) and donor (E. coli) strains of
bacteria. To construct pKN46, primer ymoA-5L, which contains an XbaI linker
(5-GCT CTA GAC ACA TAT ACT CTG TTT AGT AGT TAC GGA ATC-
3), and primer ymoA-3L, which contains a BglII linker (5-GAA GAT CTG
TTG CCA TAC AGT AGG TGG AAT TTTA TCA T-3), were used to amplify
a 360-bp product that contained most of the ymoA gene. The resulting product
was digested with XbaI/BglII and cloned into the same sites in pKN8. To gen-
erate pELL16, the promoter region (500 bp upstream of the start codon) of rovA
was amplified from JB580v with primer rovAFusexba, which contains an XbaI
linker (5-CGT CTA GAT TCC ACA TCC ACC AAC-3), and primer rovA-2,
which has a BamHI linker (5-CGC GGA TCC TGC TAA ATC AGA TCC TAA
TGT CGA TTC CAA-3). After amplification the products were digested with
XbaI/BamHI and cloned into the XbaI/BglII sites in pKN8. Plasmids were con-
firmed by sequencing.
Strains JB580c (20) and YVM976c were mated with S17-pir (29) containing
either pKN46 or pELL16 to generate chromosomal lacZ fusions. Briefly, 400 l
of overnight cultures was mixed and resuspended in 200 l of LB broth and
spotted on LB agar. The plate was incubated overnight at 26°C, and the bacteria
were harvested and resuspended in 1 ml of LB broth. Dilutions of 101 and 102
were spread on LB agar containing nalidixic acid (to select against the donor E.
coli strain), and chloramphenicol (to select for the recipient Y. enterocolitica
strain). Integration was confirmed by PCR with a primer within lacZ and a
primer 5 of the homologous region used for recombination.
Green fluorescent protein assays. Cultures of JB580v containing inv-gfp tran-
scriptional fusions were grown in 4 ml of LB broth overnight at 26°C with
selection and then subcultured to an optical density at 600 nm (OD600) of 0.2 in
3 ml of LB broth. Cultures were grown at 26 or 37°C for 24 h, and levels of
fluorescence intensity were compared. Fluorescence intensity was determined
with a Beacon 2000 variable-fluorescence polarization system (Panvera). The
fluorescence was calculated by dividing the average fluorescence intensity by the
TABLE 1. Strains and plasmids
Strain or plasmid Description Reference or source
Y. enterocolitica strainsa
JB580v Serogroup O:8 Nalr yenR(r m) 20
JB580c Serogroup O:8 Nalr yenR(r m) 20
JB41v inv-phoA inv Nalr Cmr 1
YVM567c inv-phoA inv ymoB::mTn5Kn2 Nalr Cmr This work
YVM923c ymoB Nalr This work
YVM967c ymoB inv-phoA inv Nalr Cmr This work
YVM976c ymoB::mTn5Kn2 Nalr This work
YVM1009c rovA-lacZ rovA Nalr Cmr This work
YVM1010c ymoA-lacZ ymoB Nalr Cmr This work
YVM1012c ymoB::mTn5Kn2 ymoA-lacZ Nalr Cmr This work
YVM1013c ymoB::mTn5Kn2 rovA-lacZ rovA Nalr Cmr This work
Plasmid
pBAD33 Expression vector controlled by araBAD promoter, Cmr 15
pCR2.1 TA cloning vector, Knr Ampr Invitrogen
pHG329 pUC19 polylinker, pBR322 ori, Ampr 43
pKENmut2 gfp vector, Ampr 9
pSR47s Suicide plasmid with sacB as a counter-selectable marker, Knr 25
pUTminiTn5Kn2 Transposon vector, Kmr 17
pWKS30:StrSpec pWKS30, which has a Strr-Spcr cassette in the HindIII site of the polylinker, Ampr
Strr Spcr
Laboratory collection
pWKS30 cloning vector, Ampr 46
pBY1 pCR2.1 with gfp mut2 from pKENmut2, Ampr This work
pBY8 pWKS30::Strr-Spcr with gfp mut2 from pBY1, Ampr Strr Spcr This work
pBY9 pGEM5 with 600-bp inv promoter (415 to 170 of coding region), Ampr This work
pBY10 pBY8 with 600-bp inv promoter from pBY9, Ampr Strr Spcr This work
pBY11 pCR2.1 with 215-bp inv promoter (69 to 170 of coding region), Ampr This work
pBY12 pBY8 with 215-bp inv promoter from pBY11, Ampr Strr Spcr This work
pBY34 pHG329 containing ymoBA from 11F3, Ampr Knr This work
pELL13 pBAD33 containing ymoB and ymoA and upstream promoter region, Cmr This work
pELL16 pFuse carrying sequence just upstream of rovA, Cmr This work
pELL21 pWKS30::Strr-Spcr carrying ymoB and ymoA and upstream promoter region, Cmr This work
pKN8 Suicide lacZYA reporter vector pFUSE with BglII linker cloned into smaI site,
Cmr
Laboratory collection
pKN38 pSR47S carrying upstream and downstream regions of ymoB, Knr This work
pKN46 pKN8 carrying sequence just upstream of ymoA, Cmr This work
pKN47 pWKS30:Strr-Spcr carrying ymoBA and upstream promoter region, Cmr This work
pREV2 pCR2.1 carrying inv promoter region 415 to 170 Laboratory collection
a All strains listed are derivatives of strain JB580.
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culture OD600. In all cases, JB580v with pBY8 was used to determine back-
ground fluorescence.
Screen for negative regulators of inv. Strain JB41v (1) was mutagenized with
mTn5Kn2 by mating with S17-pir containing pUTmTn5Kn2 as previously de-
scribed (17). To select for mutants that showed increased inv expression at 37°C
and neutral pH, as shown by their dark blue appearance, plates containing
nalidixic acid (to select against the donor E. coli strain), chloramphenicol (to
select for the recipient Y. enterocolitica strain), kanamycin (to select for trans-
poson insertions), and 5-bromo-4-chloro-3-indolylphosphate (XP; 40 g ml1; to
screen for alkaline phosphatase [AP] activity indicating alterations in inv pro-
moter activity) were incubated at 37°C for 2 days. Colonies were then screened
for inv-phoA expression. Of 300 mutants selected from plates 2, 6B4 and 11F3,
showed increased expression of inv-phoA at 37°C when tested by a quantitative
AP assay.
Southern blotting was performed to determine the sizes of the Knr-encoding
fragments from mutants 6B4 and 11F3. The blots were probed with the EcoRI
Knr fragment from the pUTminiTn5Kn2 plasmid. The 11F3 fragment was cloned
into pHG329 (43) by making a subgenomic library and selecting for Knr to
generate pBY34. However, the 6B4 mutation could not be cloned by this
method. Since mutant 6B4 was not malleable to cloning via a subgenomic library,
the location of the mutation was determined by Southern blotting using the
Knr-encoding fragment and ymoA as probes and PCR with primers ymo1 (5-
GAA GAT CTT GCT ATT TCA CAT GTT GCC-3), which anneals to the 3
end of ymoA and reads into ymoA, P6 (5-CCT AGG CGG CCA GAT CTG
AT-3), which anneals to the Tn5 I repeat and reads away from Tn5, and P7
(5-GCA CTT GTG TAT AAG AGT CAG-3), which anneals to the Tn5 O
repeat to read away from Tn5.
-Galactosidase assays. Cultures were grown in triplicate overnight in 2 ml of
LB broth at 37 or 26°C. -Galactosidase activity was measured according to
previously described methods (26).
AP assays. Cultures were grown in triplicate overnight in 2 ml of LB broth at
37 or 26°C. AP activity was measured according to previously described methods
(23).
Nucleotide sequence accession number. The GenBank accession number as-
signed to the ymoBA locus is AY387659.
RESULTS
Truncation of the inv promoter results in constitutive ex-
pression at 37 and 26°C. To determine if sequences upstream
of the 35 region of the inv promoter were important for
promoter function, a full-length promoter and a truncated
promoter were fused to gfp (Fig. 1). The plasmids were trans-
formed into JB580v, and levels of expression of the inv-gfp
fusions at 37 (temperature where the inv promoter is re-
pressed) and 26°C (temperature where the inv promoter is
activated) were compared (Fig. 2). pBY10 (415 to 170)
shows normal regulation at 37 and 26°C, with inv expression
elevated at 26°C compared to that at 37°C. pBY12 (69 to
170) shows derepression of the inv promoter at 37°C, with
levels of promoter activity comparable to those at 26°C. These
results suggest the presence of a repressor binding site between
positions 415 and 69 on the inv promoter.
Identification of a negative regulator of inv. Strain JB41v,
which contains a translational fusion of inv-phoA integrated on
the chromosome, was mutated with mTn5Kn2. To identify
mutants that had altered regulation at 37°C, colonies were
screened on indicator plates containing XP, which turns blue in
the presence of AP. Colonies that showed normal repression of
inv appeared light blue at 37°C. Colonies with a mutation in a
potential repressor appeared dark blue on the indicator plates
due to the increased expression of inv-phoA. Eleven indepen-
dent matings, yielding approximately 28,000 mutants, were
performed. Of the 28,000 mutants 300 appeared to have in-
creased inv-phoA expression at 37°C. These were further char-
acterized by performing AP assays at 26 and 37°C. Of the 300
mutants, 6B4 and 11F3 showed increased expression of inv-
phoA at 37°C (data not shown). These two mutants were from
independent matings.
To determine the sequences of the mutated genes in mu-
tants 6B4 and 11F3, Southern blotting was performed to iden-
tify the size of the Knr-encoding fragments in both mutants
(data not shown). The fragment from 11F3 was cloned into
pHG329, generating pBY34. Sequence analysis of the trans-
poson-chromosome junction in pBY34 indicated that the
transposon had inserted just upstream of a previously identi-
fied gene, ymoA. Because mutant 6B4 was not malleable to
cloning via a subgenomic library, the location of the mutation
was determined by Southern blot and PCR analysis (data not
FIG. 1. Schematic of inv-gfp promoter fusions and ymoBA locus.
(A) The predicted 35, 10, and 1 sites, along with the start codon
(107) and fusion junction (170) are marked on pBY10. (B) The
ymoBA locus contains a hypothetical Y. pestis gene just upstream of
ymoB and no open reading frames in the first 800 bp downstream of
ymoA. Arrows indicate the direction of transcription, and numbers of
base pairs between the genes are also indicated. Inverted triangle,
point of transposon insertion; solid black lines below the locus, regions
of the locus cloned into plasmids pKN43 (ymoB), pELL21 (ymoA), and
pKN46 (ymoA-lacZ).
FIG. 2. Effect of promoter truncation on inv-gfp expression. Over-
night cultures of Y. enterocolitica strain JB580v carrying the indicated
plasmids were grown in triplicate at 26°C, subcultured to an OD600 of
0.2, and grown for 24 h. Fluorescence from the inv-gfp fusions was
calculated by dividing average fluorescence by the OD600. pBY10
(415 to 170), which has the full-length inv promoter, and pBY12
(69 to 170), which has a truncated inv promoter, were compared.
pBY8 is the vector with promoterless gfp and was used to determine
background levels of fluorescence.
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shown). The results indicated that the transposon insertion was
in the same general location as, but in the opposite orientation
to, that in 11F3. The PCR product for 6B4 obtained with
primers P6 and ymo1 was sequenced directly with primer
ymo1, and this confirmed that the transposon was inserted 2 bp
upstream of, but in the opposite orientation as, the insertion in
11F3.
It was determined by sequencing that both 6B4 and 11F3
contained a mutation in a gene we named ymoB. YmoB has
homology to a hypothetical protein YbaJ from E. coli, which
has no known function (64% identity and 82% similarity).
Examination of the genetic locus revealed differences between
E. coli and Y. enterocolitica. The sequence upstream of ybaJ in
E. coli contains acrB, while the upstream sequence in Y. en-
terocolitica contains a hypothetical Yersinia pestis gene of un-
known function. hha is located just downstream of ybaJ in E.
coli, and further sequencing revealed that ymoA, a gene that
has been previously shown to influence regulation of Y. entero-
colitica virulence factors (10), is just downstream of ymoB.
YmoA and Hha are members of a new class of proteins that
regulate genes in response to different environmental condi-
tions (21). This raised the possibility that the insertion in ymoB
has a polar effect on the expression of ymoA, reducing the level
of ymoA transcription, leading to increased inv-phoA expres-
sion at 37°C. 6B4 was chosen from the two mutants for further
study and was designated strain YVM567c.
ymoA is able to restore wild-type inv-phoA expression in
YVM567c. To test the ability of ymoB and ymoA to restore
wild-type inv-phoA expression in YVM567c, plasmids pKN43
(ymoB) and pELL21 (ymoA) were transformed into YVM567c,
generating strains YVM567c(pKN43) and YVM567c
(pELL21). Levels of inv-phoA expression from these strains
were compared to those from wild-type strains JB41c(pKN43)
and JB41c(pELL21). All cultures were grown in LB broth
overnight at 26 or 37°C. Strain YVM567c(pKN43) showed
levels of inv-phoA expression comparable to those of
YVM567c, indicating that ymoB is not able to complement the
mutation in YVM567c. Strain YVM567c(pELL21) showed
levels of inv-phoA expression comparable to those seen in
strain JB41c(pELL21), indicating that ymoA alone was able to
complement the mutation in YVM567c (Fig. 3). JB41c and
YVM567c containing the vector showed no difference in reg-
ulation compared to JB41c and YVM567c with no plasmids
(data not shown). To further test whether or not ymoB was
involved in the repression of inv, an in-frame ymoB deletion
mutant was constructed and tested for inv expression. The
ymoB mutant, YVM967c, showed normal levels of inv expres-
sion compared to JB41c (data not shown). Together these data
suggested that the phenotype of loss of inv repression observed
with the transposon insertion mutation in ymoB was probably
due to a polar effect on ymoA expression rather than loss of
ymoB. We first tried to make an in-frame deletion of ymoA
using two different suicide plasmids, but both strategies failed.
Generation of an insertional ymoA mutant was also unsuccess-
ful. All attempts to construct a mutation in ymoA were unsuc-
cessful unless ymoA was supplied in trans on a plasmid, indi-
cating that ymoA is probably an essential gene for this
particular strain of Y. enterocolitica.
The data in Fig. 3 also suggested that YVM567c has in-
creased inv-phoA expression at 26°C compared to JB41c.
These results are consistent with previously published reports
that show a mutation in ymoA derepressed virF and the yop
regulon of the pYV virulence plasmid of Y. enterocolitica strain
W22711, which is a derivative of W22703, a wild-type O:9
strain, leading to higher levels of expression at both 26 and
37°C (10). Our data show the same type of derepression of inv
in strain YVM567c, with higher expression of inv-phoA at both
37 and 26°C.
mTn5Kn2:ymoB has a polar effect on the expression of
ymoA. To determine if the mutation in strain YVM567c has a
polar effect on the expression of ymoA, chromosomal lacZ-
ymoA fusions were constructed, generating a merodiploid. The
fusion was constructed in strains JB580c and YVM976c, gen-
erating strains YVM1010c and YVM1012c, respectively. Cul-
tures were grown in LB broth overnight at 26 or 37°C, and
FIG. 3. Effect of complementing YVM567c with ymoA and ymoB.
Cultures were grown in triplicate overnight at 26 or 37°C and assayed
for AP activity. All strains have a chromosomal inv-phoA fusion to
monitor promoter activity. JB41c is used as the wild-type control,
YVM567c contains a ymoB::mTn5Kn2 mutation, YVM567c(pKN43)
contains ymoB::mTn5Kn2 plus ymoB complementing clone, and
YVM567c(pELL21) contains ymoB::Tn5Kn2 plus ymoA complement-
ing clone.
FIG. 4. Effect of ymoB::mTn5Kn2 on the expression of ymoA. Cul-
tures were grown in triplicate overnight at 26 and 37°C and assayed for
-galactosidase activity. Both strains contain a chromosomal ymoA-
lacZ fusion to monitor promoter activity. YVM1010c (black bars) is
used as the wild-type (WT) control and is compared to YVM1012c
(gray bars), which contains the ymoB::mTn5Kn2 mutation.
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promoter activity was monitored by measuring -galactosidase
activity (Fig. 4). There was greatly reduced -galactosidase
activity in strain YVM1012c, which contains the ymoB:
mTn5Kn2 mutation, compared to that in the wild-type strain
YVM1010c. To rule out the possibility that YmoB is required
for the expression of the ymoBA locus, we complemented
YVM1012c with plasmid pKN43 and saw no difference in the
expression of lacZ compared to that of YVM1012c (data not
shown). The vector alone had no effect on expression of lacZ
in YVM1012c (data not shown). These results reveal that the
mutation in strain YVM567c exerts a polar effect on the tran-
scription of ymoA. Taken together with previous data, YmoA
appears responsible for the derepression of inv observed in
strain YVM567c.
Increased levels of rovA are not responsible for the increase
in inv-phoA expression seen in strain YVM567c. RovA has
previously been shown to be required for the expression of inv
in Y. enterocolitica and Y. pseudotuberculosis (30, 41). To rule
out the possibility that increased rovA expression in strain
YVM567c was responsible for the increased levels of inv ex-
pression, chromosomal lacZ fusions to the rovA promoter were
constructed in strains JB580c and YVM976c, yielding strains
YVM1009c and YVM1013c, respectively. Cultures were grown
overnight in LB broth at 26 and 37°C, and levels of -galacto-
sidase activity for the two strains were compared (Fig. 5). The
data show no difference in the level of rovA-lacZ expression
between strains YVM1009c and YVM1013c. These results in-
dicate that the increased inv expression observed in YVM567c
was not due to increased levels of rovA transcription in strain
YVM567c.
DISCUSSION
Invasin is an important virulence factor in Y. enterocolitica,
allowing attachment and efficient translocation of the bacteria
through M cells (38). Without inv the progress of Y. enteroco-
litica through the infection process is delayed (38). Previous
work has shown that inv is positively regulated by RovA, a
transcriptional regulator in the MarR/SlyA family (41). In this
study we have found that YmoA plays a role in the negative
regulation of inv. Promoter truncation experiments revealed
the presence of a negative regulatory sequence in the inv pro-
moter involved in temperature control of inv expression, and a
subsequent genetic screen showed that the ymoBA locus was
involved in the derepression of inv at 37°C. Complementing
the mutation in the ymoBA locus with ymoB and ymoA re-
vealed that ymoA and not ymoB was able to restore wild-type
expression of inv. A lacZ fusion to ymoA showed that the
mutation in the ymoBA locus exerted a polar effect on the
transcription of ymoA. We have also shown that the mutation
in the ymoBA locus does not affect the transcription of rovA.
These results suggest that YmoA plays a negative regulatory
role in the expression of inv.
YmoA is a member of a growing class of transcriptional
regulators with homology to histone-like proteins (21). YmoA
previously was shown to be involved in the regulation of Yop
proteins and YadA in Y. enterocolitica (10). It is not clear why
a ymoA mutant in the strain W22711 background was viable
whereas a ymoA mutation in the 8081 strain background ap-
pears to be lethal. However, the W22711 mutant was isolated
in the O:9 serotype background, and different serotypes of Y.
enterocolitica are known to have genetic differences (6, 13). It
is also possible that the ymoA mutant in the W22711 back-
ground simultaneously picked up a suppressor mutation. An-
other member of this family, Hha, has been implicated in the
regulation of hly, a pore-forming toxin, in E. coli (31). It has
also been reported that the Hha homologue from Salmonella
enterica serovar Typhimurium is involved in repressing the
invasion phenotype by altering expression of the regulatory
gene hilA (12). It is interesting that other examples of H-NS-
like proteins that regulate virulence factors have been shown to
increase expression when the temperature is shifted from 26 to
37°C. This is not the case for inv, as expression is downregu-
lated at 37°C and upregulated at 26°C, making regulation of inv
by YmoA distinct.
Recent studies have shown that Hha from S. enterica serovar
Typhimurium is able to bind specifically to the hilA promoter
(12). Other studies on Hha from E. coli have shown that Hha is
not able to bind the hly promoter specifically (33). However,
recent work has described the ability of Hha and YmoA to inter-
act with H-NS (32). Subsequent work done on the regulation of
the hly promoter showed that Hha and H-NS act together to
negatively regulate expression of hemolysin, with H-NS providing
the binding specificity for the hly promoter (22). It has been
suggested that H-NS and Hha form a multiprotein complex on
the hly promoter and repress transcription. YmoA and Hha are
functionally interchangeable, suggesting similar regulatory mech-
anisms (2). Further evidence to support a role for H-NS in the
regulation of inv comes directly from the sequence of the inv
promoter, which contains an AT-rich stretch of 30 bp centered on
the 35 sequence, raising the possibility that the promoter may
be intrinsically bent. It is widely accepted that H-NS binds to bent
DNA (11, 42). Based on the data for the regulation of hly and the
ability of YmoA to interact with H-NS, it is reasonable to spec-
ulate that YmoA and H-NS may form a repression complex at the
inv promoter.
RovA is a member of the MarR family of transcriptional
regulators, and has significant amino acid identity with SlyA
FIG. 5. Effect of ymoB::mTn5Kn2 on rovA expression. Cultures
were grown in triplicate overnight at 26 and 37°C and assayed for
-galactosidase activity. Both strains contain a chromosomal rovA-lacZ
fusion to monitor promoter activity. YVM1009c (black bars) is used as
the wild-type (WT) control and is compared to YVM1013c (gray bars),
which contains the ymoB::mTn5Kn2 mutation.
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from S. enterica serovar Typhimurium (41). When the slyA
homologue from E. coli is overexpressed, it is able to activate
clyA (cytotoxin) in laboratory strains of E. coli (34). It was
recently found that H-NS plays a role in silencing expression of
this gene in E. coli and that SlyA is able to overcome this
silencing and activate transcription from the clyA promoter
(47). Likewise, RovA is able to activate expression of the inv
promoter, and we hypothesize that it may do so by overcoming
the repression by YmoA. It remains to be seen what role if any
is played by H-NS in the regulation of inv. RovA has been
shown to bind the inv promoter (30), and it is possible that
under some conditions (e.g., 37°C) YmoA or a YmoA–H-NS
complex can interfere with RovA binding or alter the interac-
tion of RovA with the transcriptional machinery. Further ex-
periments with purified YmoA and RovA investigating their
interaction with the inv promoter will provide further evidence
for the mechanism by which the inv promoter is both repressed
and activated.
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